Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Pölzl G, Altenberger J, Baholli L, Beltrán P, Borbély A, Comin-Colet J, Delgado JF, Fedele F, Fontana A, Fruhwald F, Giamouzis G, Giannakoulas G, Garcia-González MJ, Gustafsson F, Kaikkonen K, Kivikko M, Kubica J, von Lewinski D, Löfman I, Malfatto G, Manito N, Martínez-Sellés M, Masip J, Merkely B, Morandi F, Mølgaard H, Oliva F, Pantev E, Papp Z, Perna GP, Pfister R, Piazza V, Bover R, Rangel-Sousa D, Recio-Mayoral A, Reinecke A, Rieth A, Sarapohja T, Schmidt G, Seidel M, Störk S, Vrtovec B, Wikström G, Yerly P, Pollesello P. Pölzl G, et al. Among authors: altenberger j. Int J Cardiol. 2017 Sep 15;243:389-395. doi: 10.1016/j.ijcard.2017.05.081. Epub 2017 May 23. Int J Cardiol. 2017. PMID: 28571618 Free article. Review.
[Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry].
Fruhwald FM, Ulmer H, Pacher R, Pölzl G, Dornaus C, Wieser M, Ebner C, Reiter S, Kaltenbach L, Altenberger J; Arbeitsgruppe Herzinsuffizienz der Österreichischen Kardiologischen Gesellschaft. Fruhwald FM, et al. Among authors: altenberger j. Wien Klin Wochenschr. 2011 Jun;123(11-12):378-83. doi: 10.1007/s00508-011-1591-6. Epub 2011 May 30. Wien Klin Wochenschr. 2011. PMID: 21614457 German.
Gender-related differences in patients with acute heart failure: management and predictors of in-hospital mortality.
Parissis JT, Mantziari L, Kaldoglou N, Ikonomidis I, Nikolaou M, Mebazaa A, Altenberger J, Delgado J, Vilas-Boas F, Paraskevaidis I, Anastasiou-Nana M, Follath F. Parissis JT, et al. Among authors: altenberger j. Int J Cardiol. 2013 Sep 20;168(1):185-9. doi: 10.1016/j.ijcard.2012.09.096. Epub 2012 Oct 4. Int J Cardiol. 2013. PMID: 23041090
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.
Nieminen MS, Altenberger J, Ben-Gal T, Böhmer A, Comin-Colet J, Dickstein K, Edes I, Fedele F, Fonseca C, García-González MJ, Giannakoulas G, Iakobishvili Z, Jääskeläinen P, Karavidas A, Kettner J, Kivikko M, Lund LH, Matskeplishvili ST, Metra M, Morandi F, Oliva F, Parkhomenko A, Parissis J, Pollesello P, Pölzl G, Schwinger RH, Segovia J, Seidel M, Vrtovec B, Wikström G. Nieminen MS, et al. Among authors: altenberger j. Int J Cardiol. 2014 Jun 15;174(2):360-7. doi: 10.1016/j.ijcard.2014.04.111. Epub 2014 Apr 18. Int J Cardiol. 2014. PMID: 24780540 Free article.
Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure.
Poelzl G, Altenberger J, Pacher R, Ebner CH, Wieser M, Winter A, Fruhwald F, Dornaus C, Ehmsen U, Reiter S, Steinacher R, Huelsmann M, Eder V, Boehmer A, Pilgersdorfer L, Ablasser K, Keroe D, Groebner H, Auer J, Jakl G, Hallas A, Ess M, Ulmer H; Austrian Working Group on Heart Failure. Poelzl G, et al. Among authors: altenberger j. Int J Cardiol. 2014 Jul 15;175(1):83-9. doi: 10.1016/j.ijcard.2014.04.255. Epub 2014 May 2. Int J Cardiol. 2014. PMID: 24857326
Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial.
Altenberger J, Parissis JT, Costard-Jaeckle A, Winter A, Ebner C, Karavidas A, Sihorsch K, Avgeropoulou E, Weber T, Dimopoulos L, Ulmer H, Poelzl G. Altenberger J, et al. Eur J Heart Fail. 2014 Aug;16(8):898-906. doi: 10.1002/ejhf.118. Epub 2014 Jun 11. Eur J Heart Fail. 2014. PMID: 24920349 Free article. Clinical Trial.
Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications.
Altenberger J, Gustafsson F, Harjola VP, Karason K, Kindgen-Milles D, Kivikko M, Malfatto G, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C. Altenberger J, et al. J Cardiovasc Pharmacol. 2018 Mar;71(3):129-136. doi: 10.1097/FJC.0000000000000533. J Cardiovasc Pharmacol. 2018. PMID: 28817484 Free PMC article. Review.
Repetitive levosimendan for a LION's heart?
Altenberger J, Pölzl G. Altenberger J, et al. Eur J Heart Fail. 2018 Jul;20(7):1137-1138. doi: 10.1002/ejhf.1206. Epub 2018 May 3. Eur J Heart Fail. 2018. PMID: 29722471 Free article. No abstract available.
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.
Pölzl G, Allipour Birgani S, Comín-Colet J, Delgado JF, Fedele F, García-Gonzáles MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Vrtovec B, Wikström G, Altenberger J. Pölzl G, et al. Among authors: altenberger j. ESC Heart Fail. 2019 Feb;6(1):174-181. doi: 10.1002/ehf2.12366. Epub 2018 Oct 30. ESC Heart Fail. 2019. PMID: 30378288 Free PMC article. Clinical Trial.
52 results